Trial for new Clot-Busting catheter withdrawn before starting
Disease control
Terminated
This study aimed to test a specialized catheter designed to deliver clot-dissolving medication directly to blood clots in the lungs. It planned to enroll up to 10 adults with serious but not massive lung clots. The trial was withdrawn by the sponsor before any patients were enrol…
Sponsor: Liquet Medical Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC